Products Categories
| CAS No.: | 51-83-2 |
|---|---|
| Name: | Carbachol |
| Molecular Structure: | |
|
|
|
| Formula: | C6H15 N2 O2 . Cl |
| Molecular Weight: | 182.65 |
| Synonyms: | Choline,chloride, carbamate (6CI,8CI); Ethanaminium, 2-[(aminocarbonyl)oxy]-N,N,N-trimethyl-,chloride (9CI); (2-Carbamoyloxyethyl)trimethylammonium chloride;(2-Hydroxyethyl)trimethyl ammonium chloride carbamate; Carbachol; Carbacholchloride; Carbacholin; Carbacholine; Carbacholine chloride; Carbacolina;Carbaminocholine chloride; Carbaminoylcholine chloride; Carbamiotin;Carbamoylcholine chloride; Carbamoylcholine-hydrochloride; Carbamylcholinechloride; Carbastat Intraocular; Carbochol; Carbocholin; Carbocholine; Carbyl;Carcholin; Choline carbamate chloride; Coletyl; Doryl; Doryl (pharmaceutical);Isopto Carbachol; Jestryl; Lentin; Miostat; Moryl; Vasoperif; g-Carbamoyl choline chloride |
| EINECS: | 200-127-3 |
| Density: | 1.2798 (rough estimate) |
| Melting Point: | 200-204 ºC |
| Solubility: | 1.0 g/mL |
| Appearance: | white crystalline powder |
| Hazard Symbols: |
|
| Risk Codes: | R25;R36/37/38 |
| Safety: | Deadly poison by subcutaneous, intravenous, and intraperitoneal routes. Poison by ingestion and possibly other routes. Human systemic effects by intravenous and intramuscular routes including: lowered blood pressure, venous dilation, nausea or vomiting, sweating and lachrymation (increased flow of tears). A cholinergic agent (parasympathetic nerve stimulant). When heated to decomposition it emits very toxic fumes of Cl−, NH3, and NOx. See also CARBAMATES. |
| Transport Information: | UN 2811 |
| PSA: | 52.32000 |
| LogP: | -2.50780 |

Carbachol chloride(51-83-2) is a kind of cholinergic drugs, and it is also used as parasympathetic stimulant. As a animal remedy, Carbachol chloride(51-83-2) is used for the treatment of intestinal colic.
| 1. | ivn-man TDLo:1428 ng/kg:CVS,GIT | CRSBAW Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. 113 (1933),79. | ||
| 2. | ims-hmn TDLo:6 µg/kg:EYE,CVS,SKN | SCALA9 Scalpel. 36 (1933),1. | ||
| 3. | ims-man TDLo:2857 ng/kg:CVS | CRSBAW Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. 113 (1933),79. | ||
| 4. | orl-rat LD50:40 mg/kg | JPETAB Journal of Pharmacology and Experimental Therapeutics. 58 (1936),337. | ||
| 5. | ipr-rat LD50:2 mg/kg | AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. 149 (1964),560. | ||
| 6. | scu-rat LD50:4 mg/kg | JPETAB Journal of Pharmacology and Experimental Therapeutics. 58 (1936),337. | ||
| 7. | ivn-rat LD50:100 µg/kg | JPETAB Journal of Pharmacology and Experimental Therapeutics. 58 (1936),337. | ||
| 8. | orl-mus LD50:15 mg/kg | NIIRDN “Drugs in Japan. Ethical Drugs, 6th Edition 1982” Edited by Japan Pharmaceutical Information Center. 6 (1982),182. | ||
| 9. | ipr-mus LD50:370 µg/kg | ATXKA8 Archiv fuer Toxikologie. 29 (1972),39. | ||
| 10. | scu-mus LD50:3 mg/kg |